Web-based treatment for depression in pregnancy: a feasibility study of Mum2BMoodBooster
Abstract Background Depression in pregnancy is prevalent, under-treated, and has serious impacts on the wellbeing of women and on child development. Internet programs can reach women who may not access traditional treatments due to distance, stigma or concern about taking medication. We adapted our...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-07-01
|
Series: | BMC Psychiatry |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12888-022-04111-x |
_version_ | 1811293492308082688 |
---|---|
author | Alan W. Gemmill Jessica Lee Oliva Jennifer Ericksen Charlene Holt Christopher J. Holt Jeannette Milgrom |
author_facet | Alan W. Gemmill Jessica Lee Oliva Jennifer Ericksen Charlene Holt Christopher J. Holt Jeannette Milgrom |
author_sort | Alan W. Gemmill |
collection | DOAJ |
description | Abstract Background Depression in pregnancy is prevalent, under-treated, and has serious impacts on the wellbeing of women and on child development. Internet programs can reach women who may not access traditional treatments due to distance, stigma or concern about taking medication. We adapted our online postnatal depression program, MumMoodBooster, for antenatal use. We aimed to trial feasibility, acceptability, and potential efficacy of the new Mum2BMoodBooster intervention with depressed pregnant women. Methods Twenty-seven pregnant women with Edinburgh Postnatal Depression Scale score > 11 used the program in a feasibility trial. Twenty-one had current diagnoses of major or minor depression on the Structured Clinical Interview for the DSM-IV. Assessment of symptoms occurred at screening/baseline, post-test (8 weeks post-enrollment), and at follow-up (3 months postpartum) using the Patient Health Questionnaire (PHQ-9) and the Depression Anxiety Stress Scales (DASS-21). Results In this feasibility trial, depression scores on both the PHQ-9 and the DASS-21, showed significant reductions representing large effects, with average symptom scores reduced by > 50%, and maintained in the ‘minimal or no depression’ range at 3 month follow-up. Anxiety scores also decreased significantly. Program usage was high with 74% of women visiting all six sessions. Program acceptability ratings were moderate to high. Conclusions Findings paralleled the magnitude of symptom reductions seen in randomised trials of the postnatal MumMoodBooster program, suggesting that Mum2BMoodBooster is an effective treatment for depressed pregnant women. Effective internet therapies are likely to become increasingly important as the COVID-19 pandemic continues to make face-to-face access to health care problematic during ‘lockdowns’. |
first_indexed | 2024-04-13T05:02:13Z |
format | Article |
id | doaj.art-f64b7d1247074884983e53814d989cf1 |
institution | Directory Open Access Journal |
issn | 1471-244X |
language | English |
last_indexed | 2024-04-13T05:02:13Z |
publishDate | 2022-07-01 |
publisher | BMC |
record_format | Article |
series | BMC Psychiatry |
spelling | doaj.art-f64b7d1247074884983e53814d989cf12022-12-22T03:01:17ZengBMCBMC Psychiatry1471-244X2022-07-012211910.1186/s12888-022-04111-xWeb-based treatment for depression in pregnancy: a feasibility study of Mum2BMoodBoosterAlan W. Gemmill0Jessica Lee Oliva1Jennifer Ericksen2Charlene Holt3Christopher J. Holt4Jeannette Milgrom5Parent-Infant Research Institute, Heidelberg Repatriation HospitalDepartment of Psychology, College of Health Care Science, James Cook UniversityParent-Infant Research Institute, Heidelberg Repatriation HospitalParent-Infant Research Institute, Heidelberg Repatriation HospitalAustralian College of Applied ProfessionsParent-Infant Research Institute, Heidelberg Repatriation HospitalAbstract Background Depression in pregnancy is prevalent, under-treated, and has serious impacts on the wellbeing of women and on child development. Internet programs can reach women who may not access traditional treatments due to distance, stigma or concern about taking medication. We adapted our online postnatal depression program, MumMoodBooster, for antenatal use. We aimed to trial feasibility, acceptability, and potential efficacy of the new Mum2BMoodBooster intervention with depressed pregnant women. Methods Twenty-seven pregnant women with Edinburgh Postnatal Depression Scale score > 11 used the program in a feasibility trial. Twenty-one had current diagnoses of major or minor depression on the Structured Clinical Interview for the DSM-IV. Assessment of symptoms occurred at screening/baseline, post-test (8 weeks post-enrollment), and at follow-up (3 months postpartum) using the Patient Health Questionnaire (PHQ-9) and the Depression Anxiety Stress Scales (DASS-21). Results In this feasibility trial, depression scores on both the PHQ-9 and the DASS-21, showed significant reductions representing large effects, with average symptom scores reduced by > 50%, and maintained in the ‘minimal or no depression’ range at 3 month follow-up. Anxiety scores also decreased significantly. Program usage was high with 74% of women visiting all six sessions. Program acceptability ratings were moderate to high. Conclusions Findings paralleled the magnitude of symptom reductions seen in randomised trials of the postnatal MumMoodBooster program, suggesting that Mum2BMoodBooster is an effective treatment for depressed pregnant women. Effective internet therapies are likely to become increasingly important as the COVID-19 pandemic continues to make face-to-face access to health care problematic during ‘lockdowns’.https://doi.org/10.1186/s12888-022-04111-xAntenatal depressionInternet interventionWeb-based interventionFeasibility trial, cognitive-behavioural therapy |
spellingShingle | Alan W. Gemmill Jessica Lee Oliva Jennifer Ericksen Charlene Holt Christopher J. Holt Jeannette Milgrom Web-based treatment for depression in pregnancy: a feasibility study of Mum2BMoodBooster BMC Psychiatry Antenatal depression Internet intervention Web-based intervention Feasibility trial, cognitive-behavioural therapy |
title | Web-based treatment for depression in pregnancy: a feasibility study of Mum2BMoodBooster |
title_full | Web-based treatment for depression in pregnancy: a feasibility study of Mum2BMoodBooster |
title_fullStr | Web-based treatment for depression in pregnancy: a feasibility study of Mum2BMoodBooster |
title_full_unstemmed | Web-based treatment for depression in pregnancy: a feasibility study of Mum2BMoodBooster |
title_short | Web-based treatment for depression in pregnancy: a feasibility study of Mum2BMoodBooster |
title_sort | web based treatment for depression in pregnancy a feasibility study of mum2bmoodbooster |
topic | Antenatal depression Internet intervention Web-based intervention Feasibility trial, cognitive-behavioural therapy |
url | https://doi.org/10.1186/s12888-022-04111-x |
work_keys_str_mv | AT alanwgemmill webbasedtreatmentfordepressioninpregnancyafeasibilitystudyofmum2bmoodbooster AT jessicaleeoliva webbasedtreatmentfordepressioninpregnancyafeasibilitystudyofmum2bmoodbooster AT jenniferericksen webbasedtreatmentfordepressioninpregnancyafeasibilitystudyofmum2bmoodbooster AT charleneholt webbasedtreatmentfordepressioninpregnancyafeasibilitystudyofmum2bmoodbooster AT christopherjholt webbasedtreatmentfordepressioninpregnancyafeasibilitystudyofmum2bmoodbooster AT jeannettemilgrom webbasedtreatmentfordepressioninpregnancyafeasibilitystudyofmum2bmoodbooster |